Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study.
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
The repair Schwann cell and its function in regenerating nerves.
[Additional indicators of the assessment of efficacy of disease modifying drugs (preliminary results).]
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
Brain temperature in multiple sclerosis.
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Month of birth and risk of multiple sclerosis: confounding and adjustments.
Multiple sclerosis in Isfahan, Iran: an update.
Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.
Shift.ms.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Commentary.
The Subventricular Zone is Able to Respond to a Demyelinating Lesion after Localized Radiation.
Autoantibodies to Glutamate Receptor Antigens in Multiple Sclerosis and Rasmussen's Encephalitis.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
Pages
« first
‹ previous
…
541
542
543
544
545
546
547
548
549
…
next ›
last »